However, an immunohistochemical analysis of 149 patients revealed the significantly lower expression of SALL4 in CRC (46.3%) than in atypical hyperplasia (68.0%) and normal tissue (78.9%) [162]. This evidence concerns the gene SALL4 and colorectal carcinoma.